Reduced price! Laxoberon 15 drup Expand

Laxoberon 15 drup

SCS BOEHRINGER INGELHEIM COMM.V

0053330

New

Therapeutic Indications:

More details

5,22€

tax incl.

5,80€ tax incl.

-10%

Preview the shipping fees

Calculate shipping.

Laxoberon 15 drup

.

Therapeutic Indications:

Symptomatic treatment of constipation.
By gradually reducing the dose and the occupied more and more spread, succeeds it managed to re-normalize the intestinal function.

Qualitative and quantitative composition:


Sodium Pico Sulphate 7.5 mg / 1 ml.
For excipients, see List of excipients.

Pharmaceutical form:


Oral drops, solution.

Posology and method of administration:


Adults and children over 10 years:
10 to 20 drops (= 5 to 10 mg) in one intake per day.
Children from 4 to 10 years:
5 to 10 drops (= 2.5 to 5 mg ) in one intake per day.
Children from 1 to 4 years:
about 1 drop per 5 kg body weight (= 0.5 mg) in one intake per day.
Oral use.
The drops can be mixed with water, milk or juice.
For a morning impact, Laxoberon must be taken at bedtime (latency: 6 to 12 hours).
The drop shape allows to adjust the dose and gradually reduce the dose.
Before his resort to laxativa with chronic constipation should be a first solution by adapting the diet and living habits. Chronic use of laxativa is not recommended.

This is a medicine, no prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:


for a
Hypersensitivity of the constituents of the preparation.
Inflammatory diseases of the colon. Intestinal obstruction mechanical ileus, acute abdomen including appendicitis. Abdominal pain of unknown origin. Hypersensitivity to difenylmethaanderivaten. Severe state of dehydration.

Special warnings and precautions for use:


As for all
laxativa, prolonged use should be advised to avoid a situation of dependency. If you need laxatives every day, we must identify the causes of constipation. Drug treatment of constipation is only one adjuvant therapy to support the current hygiene and dietary requirements (enrichment of the diet with vegetable fiber and drink, physical activity recommendation). Caution is needed in congestive heart failure, renal insufficiency, the elderly, and concomitant treatment with drugs that may give rise to 'torsades de pointe'.
Prolonged or excessive use may lead to electrolyte disturbances with hypokalemia, and cause constipation.
Laxoberon should not be given to children except on medical advice.
laxativa Prescribing of stimulants in children should remain the exception.

Pregnancy and lactation:


Laxoberon was already used by a limited number of pregnant women and women at reproductive age. It was never established toxic effects on the mother or the fetus. However, the rule applies here, as with all medicines, Laxoberon not be used during pregnancy except on medical advice.
Although not picosulphate passes into breast milk, Laxoberon should not be recommended during lactation.

Side effects:


Occasionally: discomfort, cramps and abdominal pain, diarrhea with risk of dehydration in the elderly.
Freestanding cases of allergic reactions, including skin reactions and angioedema were reported.
Chronic use can lead to disorders of electrolyte balance and histological lesions that may result in a permanent impairment of the peristalsis. Excessive use of this drug may cause hypokalemia, a risk of cardiac arrhythmias with it. Very high doses of greater than 10 mg in adults, can cause an ischemic colitis.

Effects of drive and the ability to machines:


No data available.

Overdose:


Symptoms.

in acute poisoning: diarrhea, abdominal cramps, dehydration, solid electrolytes, solid electrolyte loss, including potassium.
Cases of ischemia of the colonmucosa reported using significantly higher doses than recommended doses.
Chronic overdose can lead to chronic diarrhea, abdominal pain, hypokalemia, secondary aldosteronism, and renal stones.
With chronic use of laxativa were kidney injury, metabolic alkalosis and secondary muscle weakness caused by hypokalemia reported.
treatment.

Immediately after taking Laxoberon its absorption may significantly diminish or even be prevented due to the occurrence of vomiting or gastric lavage. In this case the necessary water and electrolyte balance to recover, especially in elderly patients and children. Administration of a spasmolyticum may be useful.

List of excipients:


Sodium methyl (Methylparaben) - sorbitol 70% - Hydrochloric acid - purified water.

Interaction with other medicinal products and other forms of interaction:


Concomitant use of diuretics or high doses Laxoberon and adrenocorticosteroïden the risk of a disorder of the electrolyte balance to increase, which in turn sensitivity to cardiac glycosides may increase tone.
The effect of Laxoberon can be weakened by the simultaneous administration of broad-spectrum antibiotics.
One should take into account a potential interaction with digitalis preparations, such interaction would theoretically be possible with antiarrhythmic drugs .
Since the risk of 'torsades de pointe 'increases with hypokalemia, caution in patients taking medicines called' torsades de pointe 'may trigger.

Incompatibilities:


No data available.

 

Delivery form Drops
Type of product Medicine
Brands Other

This is a medecine

This is a medecine available without a prescription.. Do not use long without medical advice. Read the instructions carefully. Keep this medicine out of the reach of children. Keep the manual as it contains important information. Ask for advice from your doctor or pharmacist. Consult your doctor if adverse reactions.

'

  • Fagg

Manufacturers

PayPal